Home arrow Publication Series arrow Stakeholder Opinions arrow Stakeholder Opinions: Minimally Invasive Spinal Surgery...
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Publication Series arrow Stakeholder Opinions arrow Stakeholder Opinions: Minimally Invasive Spinal Surgery...

Stakeholder Opinions: Minimally Invasive Spinal Surgery...


Price: $3 800.00


Full Title: Stakeholder Opinions: Minimally Invasive Spinal Surgery - Surgeons Await Helping Hand from Manufacturers

Introduction

As in other areas of surgery, surgeons are looking to reduce the invasive nature of spinal surgery, in an attempt to improve patient outcomes. The potential benefits of minimally invasive spinal surgery such as microdiscectomy and mini spinal fusion include: reduced morbidity and blood loss, faster rehabilitation, shorter hospital stays, and the economic benefit of returning to work earlier.

Scope

  • Analysis of opinions from leading spinal surgeons and minimally invasive spinal surgery pioneers, including thought-leader interview transcripts
  • Evaluation of microdiscectomy, percutaneous and mini-open fusion, and laparoscopic techniques: benefits, learning curve, and surgeon perception
  • Coverage of key companies and products in minimally invasive spinal surgery arena
  • Specific recommendations for companies looking to expand their minimally invasive spinal surgery product portfolio

Highlights

Minimally invasive spinal surgery techniques continue to be refined, but surgeons suggest that widespread uptake is dependent on companies improving the design of instruments and implants.

While BMPs and similar technologies may help drive minimally invasive spinal surgery, artificial discs will negatively impact this trend, giving companies several potential areas of focus to drive spinal revenues.

Reasons to Purchase

  • Understand the potential benefits, and current limitations of, minimally invasive spinal surgery
  • Identify areas of unmet need that, when addressed, will help your spinal business grow
  • Consider current surgeon opinion regarding the future of minimally invasive spinal surgery, from competitive technologies to innovative therapies

Pages: 68

Table of Contents

Download TOC in PDF




:

 


Download Fax Order Form/ PO Form

Request free sample pages from this product















Featured Products


Cancer Drug Resistance 2008
$2 995.00
$2 396.00
You Save: 20.00%

Future Focus: Myelodysplastic Syndrome
$26 250.00
$19 687.50
You Save: 25.00%

Future Focus: Gastrointestinal Stromal Tumor
$26 250.00
$19 687.50
You Save: 25.00%

Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market
$3 350.00
$2 680.00
You Save: 20.00%

Search Products

Advanced Search

Your Cart

Show Cart
Your Cart is currently empty.
Advertisement
 
 
 
© 2008 BioMarket Group